Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis

OBJECTIVE: Recent studies have raised concern about the cardiovascular safety of dipeptidyl peptidase-4 (DPP4) inhibitors. We performed a systematic review through meta-analysis to compare cardiovascular outcomes of sulfonylurea (SU) versus DPP4 inhibitors when used in combination with metformin. ME...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Lipid Atheroscler
Main Authors: Jeon, Won Kyeong, Kang, Jeehoon, Kim, Hyo-Soo, Park, Kyung Woo
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Lipidology and Atherosclerosis 2021
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8159755/
https://ncbi.nlm.nih.gov/pubmed/34095013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12997/jla.2021.10.2.210
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados